These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34905555)

  • 21. Structure-kinetic relationship of carbapenem antibacterials permeating through E. coli OmpC porin.
    Tran QT; Pearlstein RA; Williams S; Reilly J; Krucker T; Erdemli G
    Proteins; 2014 Nov; 82(11):2998-3012. PubMed ID: 25082756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural systems biology evaluation of metabolic thermotolerance in Escherichia coli.
    Chang RL; Andrews K; Kim D; Li Z; Godzik A; Palsson BO
    Science; 2013 Jun; 340(6137):1220-3. PubMed ID: 23744946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of a method to rapidly assay bacterial persister metabolism.
    Orman MA; Brynildsen MP
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4398-409. PubMed ID: 23817376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
    Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
    Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and Structure-Activity Relationships of Novel Compounds that Potentiate the Activities of Antibiotics in Escherichia coli.
    Haynes KM; Abdali N; Jhawar V; Zgurskaya HI; Parks JM; Green AT; Baudry J; Rybenkov VV; Smith JC; Walker JK
    J Med Chem; 2017 Jul; 60(14):6205-6219. PubMed ID: 28650638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large-scale High-throughput Screening Revealed 5'-(carbonylamino)-2,3'- bithiophene-4'-carboxylate as Novel Template for Antibacterial Agents.
    Ivanenkov YA; Yamidanov RS; Osterman IA; Sergiev PV; Aladinskiy VA; Aladinskaya AV; Terentiev VA; Veselov MS; Ayginin AA; Skvortsov DA; Komarova KS; Zagribelnyy BA; Baimiev AK; Shvetc KY; Baimiev AK; Sofronova AA; Machulkin AE; Petrov RA; Zainullina LF; Maximova MA; Zileeva ZR; Vakhitova YV; Bezrukov DS; Puchinina MM; Dontsova OA
    Curr Drug Discov Technol; 2020; 17(5):716-724. PubMed ID: 31161993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico pharmacology for drug discovery: applications to targets and beyond.
    Ekins S; Mestres J; Testa B
    Br J Pharmacol; 2007 Sep; 152(1):21-37. PubMed ID: 17549046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The marC gene of Escherichia coli is not involved in multiple antibiotic resistance.
    McDermott PF; McMurry LM; Podglajen I; Dzink-Fox JL; Schneiders T; Draper MP; Levy SB
    Antimicrob Agents Chemother; 2008 Jan; 52(1):382-3. PubMed ID: 17954692
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibiotic induced autolysis in Escherichia coli is independent of the level of lysozyme inhibitor ivy, but increases with plasmid insertion.
    Deckers D; Masschalck B; Aertsen A; Michiels CW
    Commun Agric Appl Biol Sci; 2005; 70(2):87-90. PubMed ID: 16366281
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanistic insights into transferable polymyxin resistance among gut bacteria.
    Xu Y; Lin J; Cui T; Srinivas S; Feng Y
    J Biol Chem; 2018 Mar; 293(12):4350-4365. PubMed ID: 29462787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Chemoinformatics, Bioinformatics, and Bioassay to Predict and Explain the Antibacterial Activity of Nonantibiotic Food and Drug Administration Drugs.
    Kahlous NA; Bawarish MAM; Sarhan MA; Küpper M; Hasaba A; Rajab M
    Assay Drug Dev Technol; 2017 Apr; 15(3):89-105. PubMed ID: 28346800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and functional insights into MCR-2 mediated colistin resistance.
    Wang X; Lu Q; Qi J; Chai Y; Wang Y; Gao GF
    Sci China Life Sci; 2018 Nov; 61(11):1432-1436. PubMed ID: 30194678
    [No Abstract]   [Full Text] [Related]  

  • 34. Systematic Analysis of Intracellular-targeting Antimicrobial Peptides, Bactenecin 7, Hybrid of Pleurocidin and Dermaseptin, Proline-Arginine-rich Peptide, and Lactoferricin B, by Using Escherichia coli Proteome Microarrays.
    Ho YH; Shah P; Chen YW; Chen CS
    Mol Cell Proteomics; 2016 Jun; 15(6):1837-47. PubMed ID: 26902206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
    Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
    J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria.
    Moreau RJ; Skepper CK; Appleton BA; Blechschmidt A; Balibar CJ; Benton BM; Drumm JE; Feng BY; Geng M; Li C; Lindvall MK; Lingel A; Lu Y; Mamo M; Mergo W; Polyakov V; Smith TM; Takeoka K; Uehara K; Wang L; Wei JR; Weiss AH; Xie L; Xu W; Zhang Q; de Vicente J
    J Med Chem; 2018 Apr; 61(8):3309-3324. PubMed ID: 29498517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K; Khan W; Azam SS; Wadood A
    Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of New Antibacterial Enhancers Based on AcrB's Structure and the Evaluation of Their Antibacterial Enhancement Activity.
    Song Y; Qin R; Pan X; Ouyang Q; Liu T; Zhai Z; Chen Y; Li B; Zhou H
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.
    Ito R; Tomich AD; McElheny CL; Mettus RT; Sluis-Cremer N; Doi Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards creating an extended metabolic model (EMM) for E. coli using enzyme promiscuity prediction and metabolomics data.
    Amin SA; Chavez E; Porokhin V; Nair NU; Hassoun S
    Microb Cell Fact; 2019 Jun; 18(1):109. PubMed ID: 31196115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.